MACUSTAR | Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076
01-09-2017
-31-05-2024
01-09-2017
-31-05-2024
01-12-2022
-30-11-2026
01-09-2022
-31-08-2027
01-01-2019
-30-09-2022
01-04-2020
-31-03-2024
01-09-2020
-28-02-2025
01-02-2016
-31-01-2020
01-07-2021
-30-06-2025
01-01-2025
-31-12-2028
01-06-2022
-31-05-2027
01-10-2022
-30-09-2026
01-12-2015
-30-11-2018
01-01-2016
-31-12-2019
01-01-2019
-30-06-2022
01-07-2022
-30-06-2027
01-01-2019
-30-06-2021
01-08-2020
-31-01-2025
01-10-2017
-30-09-2020
01-01-2016
-31-12-2018
01-10-2020
-31-03-2023
01-10-2019
-31-03-2024
01-09-2023
-31-08-2026
01-12-2024
-30-11-2028
01-01-2018
-31-12-2024
01-01-2023
-31-12-2026
01-02-2023
-31-01-2027
01-01-2024
-31-12-2028
01-04-2021
-31-03-2025
01-01-2025
-31-12-2028
01-01-2024
-31-12-2027